通过配对关联刺激诱导的神经可塑性的多巴胺基调节NMDA受体的参与
Marie C Beaupain1,2, Elham Ghanavati1,2, Amba M Frese1,3,4
1Department of Psychology and Neurosciences, Leibniz Research Centre for Working Environment and Human Factors (IfADo), Dortmund, Germany.
The international journal of neuropsychopharmacology
|May 29, 2025
概括
最佳的N-甲基-D-酸盐 (NMDA) 受体激活对于多巴胺调节的神经可塑性至关重要. 通过降低NMDA受体功能,D2受体活性可能会损害长期的强化效应,特别是对敏感性较低的人.
科学领域:
- 神经科学是一个神经科学.
- 神经生理学 神经生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多巴胺 (DA) 影响神经可塑性,特别是长期强化 (LTP) 效应.
- D1和D2受体通过NMDA和GABA通路参与调节神经可塑性,但机制尚不清楚.
研究的目的:
- 研究NMDA受体活性在焦点LTP类可塑性多巴胺调节中的作用.
- 检查多巴胺类药物和D-环素 (CYC) 对激发性配对关联刺激 (ePAS) 诱导的神经可塑性的影响.
主要方法:
- 这是一项双盲,随机,安慰剂控制的研究,涉及17名健康参与者.
- 使用L-多巴,布罗莫克里普丁或安慰剂,与不同剂量的D-环素 (CYC) 或安慰剂相结合.
- 在ePAS后使用跨磁刺激 (TMS) 诱导的运动唤起潜能监测皮层刺激性.
主要成果:
- 多巴胺类药物和CYC之间没有总体相互作用,但基于ePAS敏感性的群体差异被观察到.
- 在高灵敏度参与者中,ePAS诱导了类似LTP的效应;CYC显示非线性,剂量依赖的效应.
- 勃罗莫克里在高敏感性组中降低了LTP类效应;L-Dopa与中剂量CYC相结合在低敏感性组中恢复了效应.
结论:
- 最佳的NMDA受体激活对于ePAS诱导的神经可塑性至关重要.
- D2受体活性可能通过降低NMDA受体功能的调节来减弱LTP效应.
相关概念视频
Long-term Potentiation
2.9K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.9K
Role of Neurotransmitters in Memory
1.0K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
1.0K
Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K
Neuroplasticity
808
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
808
Long-term Depression
2.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.6K


